Association of coagulation factor V(Arg506Gln) mutation with non-insulin-dependent diabetes mellitus [16]

Lancet

Volumn 348, Issue 9042, 1996, Pages 1666-1667

  Krekora, K ^a   De Lucia, D ^a   Capani, F ^a   Donati, M B ^a   Iacoviello, L ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5;

ADULT; AGED; ARTERY THROMBOSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE MUTATION; HEMOSTASIS; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; VEIN THROMBOSIS;

EID: 0030470762     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)65740-6     Document Type: Letter

References (5)

1. RM Bertina BPC Koeleman T Koster Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64 67
2. B Zoller B Dahlback Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis Lancet 343 1994 1536 1538
3. DC Rees M Cox JB Clegg World distribution of factor V Leiden Lancet 346 1995 1133 1134
4. MP Stern Diabetes and cardiovascular disease. The “Common Soil” hypothesis Diabetes 44 1995 369 374
5. MW Mansfield MH Stickland P Grant Plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism and coronary artery disease in non-insulin-dependent diabetes Thromb Haemost 74 1995 1032 1034